People In The News: New Top Leadership At IoM, Avillion, Sucampo; Former FDA Orphan Drug Head Update
Executive Summary
The Institute of Medicine names Victor Dzau president; Avillion names Jeynes-Ellis CEO, while Sucampo introduces Greenleaf as its new CEO; Former FDA Office of Orphan Drug Product Development Director Timothy Cote joins Xenetic Biosciences board; more announcements in this month’s column.